Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Statistical Analysis All statistical analyses were conducted using the SPSS version 17.0 (SPSS, Chicago, Illinois, USA)
Very good service , fast and efficient delivery
Ask your provider for recommendations
Abstract Background The potential benefits and risks of combination therapy with sodium-glucose co-transporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus monotherapy remain a subject of debate to optimize metabolic and cardiovascular outcomes in patients with type 2 diabetes mellitus
US$ 26.01
US$ 25.26
US$ 25.70
US$ 20.09
